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Abstract
Background: Differences in error rates between pharmacists and nurses in terms of drug confirmation have not
been studied. The purpose of this study was to analyze differences in error rates between pharmacists and nurses
from the viewpoint of error categories, and to clarify differences in recognition regarding drug name similarity.
Methods: In this study, preparation errors and incidents were classified into three categories (drug strength errors,
drug name errors, and drug count errors) to investigate the influence of error categories on pharmacists and nurses. In
addition, errors in two categories (drug strength errors and drug name errors) were reclassified into another two error
groups, to investigate the influence of drug name similarity on pharmacists and nurses: a “drug name similarity (−) group”
and a “drug name similarity (+) group”. Then, differences in error rates of pharmacists and those of nurses were analyzed
respectively within three categories and two groups. Furthermore, differences in error rates between pharmacists and
nurses were analyzed in each of the three categories and two groups.
Results: Error rates of pharmacists for both drug strength errors and drug name errors were significantly higher than that
for drug count errors, and similar results were obtained for nurses (P < 0.05). However, there were no significant
differences in error rates between pharmacists and nurses in each of the three categories. Furthermore, error rate
of nurses was significantly higher than that of pharmacists in the drug name similarity (+) group (P < 0.05), while
there was no significant difference in error rates between pharmacists and nurses in the drug name similarity (−)
group.
Conclusions: These results suggest that in contrast to pharmacists, nurses are easily affected by similarities in
drug names. Therefore, pharmacists should offer information on medications having plural strengths or similar
names to nurses, in order to minimize damage to patients resulting from errors.
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Background
Though standards of security in healthcare have advanced,
medical incidents and accidents continue to occur. In the
department of pharmacy at Kyushu University Hospital, we
have been working on countermeasures to prevent inci-
dents regarding oral and external medications. We have
maintained an occurrence rate of these incident types in
the range of 0.027–0.036% for eight years, since April 2006
[1-4]. As a matter of course, pharmacists are fully
accountable for these incidents. Therefore, pharmacists
should make every effort to prevent incidents caused by
their own errors. On the other hand, it is also import-
ant for pharmacists to recognize the categories of drug
errors that are liable to be overlooked by pharmacists,
lead to administration to patients, and cause serious
damage to patients. On a practical level, it is impossible
for pharmacists to prevent administration after the de-
livery of incorrect medications. Concerning the man-
agement of inpatient medication, nurses check all
medications prior to administration in our hospital.
Therefore, it is clear that nurses play an important role
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in preventing administration of incorrect drugs. In
short, nurses minimize the patient damage by detecting
the mistakes overlooked by pharmacists.
Many reports exist regarding prevention measures for in-
cidents caused by pharmacists [18], and many analytical
studies have been conducted regarding the probability of
drug name confusion [9–14]. However, differences in medi-
cation error rates between pharmacists and nurses have not
yet been studied.
In the present study, preparation errors and incidents
were classified into three categories (drug strength errors,
drug name errors, and drug count errors). Furthermore,
drug strength and drug name errors were classified into
two groups: drug name similarity (−) or drug name similar-
ity (+). Then, differences in error rates between pharmacists
and nurses were analyzed within and across these three cat-
egories and two groups.
Methods
Study period and subject of investigation
The study period lasted eight years, from April 2006 to
March 2014. Preparation errors and incidents regarding
oral medications among inpatient prescriptions were inves-
tigated. Among these, errors pertaining to narcotics, pow-
ders, and tablets divided by the automatic packaging
machine were excluded from investigation, because of the
difference in dispensing procedures. Furthermore, the in-
vestigation was restricted to errors that could be classified
into three categories (drug strength, drug name, and drug
count errors).
Preparation error data was self-reported by pharmacy
inspectors, and incident data was reported by nurses.
Also, it was not necessary to obtain written informed
consent by each patient in the present retrospective
study based on the ethical guidelines for clinical studies
by Ministry of Health, Labor and Welfare, Japan. The in-
dividual information concerning patients was protected
appropriately. In addition, problems regarding the occur-
rence of preparation errors by pharmacists were not a
concern, because these errors were regarded as the
population parameter for the calculation of error rates
of pharmacists in this study.
Definition of incidents and classification of incident
impact on patients
We defined errors detected by nurses or inpatients after
being overlooked by pharmacy inspectors as “incidents”.
According to the provisions of the National University
Hospital in Japan, the impact on patients of the inci-
dents was classified into six stages (Levels 0–5) as de-
scribed below.
Level 0: Incorrect drug was delivered to the nurse, but
it was not taken by a patient.
Level 1: Incorrect drug was taken by a patient, but pa-
tient was not adversely affected.
Level 2: Moderate impact to the patient, but treatment
was not needed.
Level 3: Provisional or continual treatment was needed.
Level 4: Severe impact on the patient remained.
Level 5: Patient died.
Definition of preparation errors, incidents more than
Level 0, and incidents more than Level 1
We defined errors detected by pharmacy inspectors as
“preparation errors”, errors not detected by pharmacy in-
spectors as “incidents more than Level 0”, and errors that
led to administration after being overlooked by nurses as
“incidents more than Level 1”. In this study, practical prep-
aration errors were considered equivalent to an “all errors”
that including incidents more than Level 0, because these
incidents were simply not detected by the pharmacists at
the point of inspection.
In short, the number of preparation errors included
that of incidents more than Level 0, and the number of
incidents more than Level 0 included that of incidents
more than Level 1. The definition of preparation errors,
incidents more than Level 0, and incidents more than
Level 1 was summarized as described below.
Preparation errors: Errors that were revealed to be
incorrect afterward. These were equivalent to an “all
errors” category, and included errors detected by phar-
macy inspectors.
Incidents more than Level 0: Errors that were not de-
tected by pharmacy inspectors and led to delivery of
medication to nurses.
Incidents more than Level 1: Errors that were not de-
tected by nurses and led to administration of medication
to patients.
Classification of preparation errors and incidents into
three categories
Preparation errors and incidents were classified into three
categories (drug strength, drug name, and drug count er-
rors) to investigate the influence of error categories on
pharmacists and nurses. The error rates of pharmacists
were calculated by dividing the number of incidents more
than Level 0 by that of preparation errors (incidents more
than Level 0/preparation errors). The error rates of nurses
were calculated by dividing the number of incidents more
than Level 1 by that of incidents more than Level 0 (inci-
dents more than Level 1/incidents more than Level 0).
Then, differences in error rates of pharmacists and those of
nurses were analyzed respectively within three categories.
Furthermore, the differences in the error rates between
pharmacists and nurses were analyzed in each of three
categories.
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Reclassification of preparation errors and incidents into
two groups
Trade names of Japanese drugs are expressed by kata-
kana in most cases. In Japanese, katakana expressions
consists of both orthographic (i.e., spelling) and phono-
logical (i.e., pronunciation) aspects. In the present study,
katakana trade names were converted into Romanized
versions of Japanese (non-English words Romanized
using Hepburn's method), to represent the exact fea-
tures of the katakana.
In order to investigate the influence of drug name simi-
larity on pharmacists and nurses, preparation errors and in-
cidents in two categories (drug strength errors and drug
name errors) were first totaled. Then, these errors were re-
classified into two further error groups: “having less than
four letters in common” or “having more than five letters in
common”, from the viewpoint of drug name similarity.
If the correct drug and incorrect drug had the same drug
strength, we defined this as equivalent to “one additional
letter” in terms of having continuous letters in common.
For example, “PU/RA/BI/KKU/SU (75)” and “PU/RA/ZA/
KI/SA (75)” share four letters and drug strength; the under-
lines represent the common points between them. In this
case, we defined this error group as “having more than five
letters in common”. Furthermore, we defined the error
group “having less than four letters in common” as the
“drug name similarity (−) group”, and the error group “hav-
ing more than five letters in common” as the “drug name
similarity (+) group”. Additional file 1: Table S1 shows the
classification of the errors into two groups and examples of
errors.
Then, the differences in error rates of pharmacists and
those of nurses were analyzed respectively within the
two groups. Furthermore, the differences in the error
rates between pharmacists and nurses were analyzed in
each of two groups.
Data analysis
Data were analyzed with a chi-square test. P values of <0.05
were considered statistically significant, and P values
of <0.1 were considered marginally statistically signifi-
cant. Differences in error rates of pharmacists and
those of nurses were analyzed respectively among
three categories and between two groups. In addition,
the differences in the error rates between pharmacists
and nurses were analyzed in each of three categories
and two groups.
Results
Number of preparation errors, and incidents more than
Level 0, 1, and 2
Over the eight years, 758,310 inpatient prescriptions were
given. The number of preparation errors in the three cat-
egories (drug strength, drug name, and drug count errors)
were 392,650, and 2,588, the number of incidents more
than Level 0 were 38,73, and 117, the number of incidents
more than Level 1 were 6, 9, and 2, and the number of in-
cidents more than Level 2 were 2, 5, and 0, respectively.
There were no incidents more than Level 3.
Figure 1 shows the occupancy rates for each stage from
“preparation errors” to “incidents more than Level 2” in
the three categories. The occupancy rates of preparation
errors, incidents more than Level 0, 1, and 2 in the cat-
egory of drug count errors were 71.3% (2588/3630), 51.3%
(117/228), 11.8% (2/17), and 0% (0/7), respectively. In con-
trast, the same rates in the category of drug name errors
were 17.9% (650/3630), 32.0% (73/228), 52.9% (9/17), and
71.4% (5/7), respectively. In addition, the same rates in the
category of drug strength errors were 10.8% (392/3630),
16.7% (38/228), 35.3% (6/17), and 28.6% (2/7), respect-
ively. Furthermore, Fig. 2 shows the schematic view of the
number of preparation errors, incidents more than Level
0, and incidents more than Level 1 in three categories (a)
and two groups (b).
Error rates of pharmacists and nurses in three categories
Figure 3 shows the error rates of pharmacists and nurses in
three categories. Distributions of both preparation errors
and incidents more than Level 0 showed a similar tendency
in the following order: drug strength errors < drug name
errors < drug count errors.
Error rates of pharmacists in three categories (drug
strength, drug name, and drug count errors) were 9.7% (38/
392), 11.2% (73/650), and 4.5% (117/2588), respectively. In
addition, the error rate of pharmacists in the category of
drug name errors was the highest among the three categor-
ies. The respective error rates of pharmacists in the categor-
ies of both drug strength errors and drug name errors were
significantly higher than for the category of drug count
errors (P < 0.05).
In contrast, the error rates of nurses in the three
categories (drug strength, drug name, and drug count
errors) were 15.8% (6/38), 12.3% (9/73), and 1.7% (2/
117), respectively. Error rate of nurses in the category
of drug strength errors was the highest among the
three categories. Furthermore, the respective error
rates of nurses in the categories of both drug strength
errors and drug name errors were significantly higher
than for the category of drug count errors (P < 0.05).
In short, these results suggest that nurses are good at
detecting drug count errors, but poor at detecting
drug strength errors.
Furthermore, there were no significant differences in
error rates between pharmacists and nurses in each of
the three categories. Among them, difference in error
rates between pharmacists and nurses was greatest in
the category of drug strength errors.
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Error rates of pharmacists and nurses in two groups
Figure 4 shows the error rates of pharmacists and nurses
in two groups. The distributions of both preparation er-
rors and incidents more than Level 0 showed a similar
tendency: drug name similarity (−) group > drug name
similarity (+) group.
The respective error rates of pharmacists in the drug
name similarity (−) and (+) group were 11.8% (68/576)
and 9.2% (43/466), and there was no significant differ-
ence in the error rates of pharmacists between the two
groups. On the other hand, the respective error rates of
nurses in the drug name similarity (−) and (+) group
were 8.8% (6/68) and 20.9% (9/43), and there was a mar-
ginally significant difference in the error rates of nurses
between the two groups (P = 0.069).
Furthermore, there was no significant difference in
error rates between pharmacists and nurses (11.8% and
8.8%) in the drug name similarity (−) group. On the
other hand, there was a significant difference in error
rates between pharmacists and nurses (9.2% and 20.9%)
in the drug name similarity (+) group (P < 0.05). In short,
these results suggest that nurses are easily affected by
similarities in drug names in contrast to pharmacists.
Discussion
The occupancy rates of preparations errors, incidents more
than Level 0, 1, and 2 in the category of drug count errors
decreased gradually in accordance with a rise in impact to
the patient. In contrast, the same rates in the category of
drug name errors increased gradually, and a similar ten-
dency was seen in the category of drug strength errors. In
short, greater impact on patients is seen in the following
order: drug name errors > drug strength errors > drug count
errors. Furthermore, the transition rate from “preparation
errors” to “incidents more than Level 0” was highest for
drug name errors (11.2%; 73/650). In addition, the same
rate from “incidents more than Level 0” to “incidents more
than Level 1” was highest for drug strength errors (15.8%;
6/38). Finally, the same rate from “incidents more than
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Fig. 1 Occupancy rates of preparation errors, and incidents more than Level 0, 1, and 2 in three categories. The number in parenthesis indicates
the total number of errors of three categories (drug count errors, drug strength errors, drug name errors). Occupancy rate indicates the
percentage of the number of each category to the total number. The occupancy rates at the respective stages from “preparation errors” to
“incidents more than Level 2” are indicated according to three categories
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drug name errors (55.6%; 5/9). These results suggest that
pharmacists tend to make drug name errors, nurses tend to
make drug strength errors, and inpatients tend to suffer
serious damage after taking incorrect drugs, which is re-
lated to drug name errors.
Again, pharmacists are fully accountable for these inci-
dents, because the root causes of them are made by the
pharmacists. Therefore, in the first place, pharmacists
should make every effort to keep the incidents to the mini-
mum. In addition, pharmacy inspectors should prevent
preferentially the high-risk incidents by recognizing that ex-
pansion of patient damage is caused in the following order:
drug name errors > drug strength errors > drug count er-
rors. As a countermeasure for preventing these mistakes,
pharmacy inspectors are working on confirming thoroughly
“identification code” indicated on the exterior of each
medication. Medication identification codes are indi-
cated on the prescription through coordination at our
hospital pharmacy. Therefore, it is possible to compare
medication and prescription codes. For example, the identi-
fication codes: “PURABIKKUSU (75)”, “PURAZAKISA
(75)”, “PURABIKKUSU (25)”, and “PURAZAKISA (110)”
are expressed as “sa 75”, “R 75”, “sa 25”, and “R 110” re-
spectively (The underlines represent the common
points among trade names in Romanized Japanese). Be-
cause the identification code is typically a simple and
unique combination of numbers, symbols, and so on, it
is unlikely for pharmacy inspectors to be influenced by
preconceptions in terms of comparing the two codes.
In fact, the error rate of pharmacists in the category of
drug count errors was significantly lower than that of
the other two categories (drug strength and drug name
errors), and the same results were obtained for the
error rates of nurses. These results suggest that con-
firmation utilizing numerical values or symbols would
be a simple and effective method that would not be af-
fected by preconceptions.
From the viewpoint of drug name similarity, error rate of
nurses was significantly higher than that of pharmacists in
the drug name similarity (+) group (20.9%, 9.2%; P < 0.05).
Furthermore, error rate of nurses in the drug name similar-
ity (+) group tended to be higher than that in the drug
name similarity (−) group (20.9%, 8.8%; P = 0.069). In other
words, compared to pharmacists, nurses are easily affected
by similarities in drug names. These results suggest that
there is a difference in recognition regarding similarities in
drug names between pharmacists and nurses. The main
reason for these errors by nurses is likely to be a lack of
knowledge of the medications that cause the risk of name
confusion.
However, unlike pharmacists, nurses cannot confirm
identification codes in hospital wards or at nurse sta-
tions. Therefore, it is necessary for pharmacists to offer
information on medications having multiple strengths or
Fig. 2 Schematic view of the number of preparation errors, incidents more than Level 0, and incidents more than Level 1 in three categories (a)
and two groups (b). Preparation errors and incidents were classified into three categories (c: drug strength errors, drug name errors, drug count
errors). And these errors in two categories (drug strength errors, drug name errors) were reclassified into another two groups (b: drug name
similarity (−) group, drug name similarity (+) group). Circles indicate the number of preparation errors, hexagons indicate the number of incidents
more than Level 0, and pentagons indicate the number of incidents more than Level 1, respectively. The number of preparation errors includes
that of incidents more than Level 0, and the number of incidents more than Level 0 includes that of incidents more than Level 1
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similar names to nurses. For example, publishing a list
of these medications would help nurses to recognize the
presence of medications causing a risk for name confu-
sion. Such measures would help in education on medical
safety for nurses as well as pharmacists, and would lead
to a subsequent reduction of serious damage to patients.
Conclusions
Our results suggest that increasing damage is caused to pa-
tients by errors in the following order: drug name errors >
drug strength errors > drug count errors. Therefore, phar-
macists should make efforts specifically to prevent high-risk
errors, such as drug name errors. Furthermore, there was
no difference in error rates between pharmacists and nurses
from the viewpoint of error categories, while there was a
difference in error rates between them for drug name
similarities. In short, in contrast to pharmacists, nurses are
easily affected by similarities in drug names, which suggests
a difference in recognition of drug names between pharma-
cists and nurses. Therefore, it is necessary for pharmacists
to offer information to nurses on medications having mul-
tiple strengths or similar names, in order to minimize dam-
age to patients due to medication errors.
Additional file
Additional file 1: Table S1. Classification of errors into two groups and
examples of errors. (PDF 169 KB)
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Circles represent the error rates of pharmacists and nurses, respectively.
Bars represent the number of preparation errors and incidents more than Level 0, respectively.
Fig. 3 Error rates of pharmacists and nurses in three categories. Preparation errors and incidents were classified into three categories (drug
strength errors, drug name errors, drug count errors). Open circles indicate the error rates of pharmacists and closed circles indicate the error
rates of nurses, respectively. Bars in the left figure indicate the number of preparation errors and bars in the right figure indicate the number of
incidents more than Level 0, respectively. Data were analyzed with a chi-square test. P values of <0.05 were considered statistically significant
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